Stay updated with breaking news from Frazier Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $8.46 and traded as high as $8.94. Alpine Immune Sciences shares last traded at $8.80, with a volume of 60,111 shares changing hands. Analyst Upgrades and […]
Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 802,000 shares, an increase of 38.6% from the May 15th total of 578,600 shares. Approximately 1.4% of the company’s shares are sold short. Based on an average […]
Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) CEO Eric Dobmeier purchased 5,000 shares of the stock in a transaction on Wednesday, May 25th. The shares were purchased at an average cost of $13.03 per share, for a total transaction of $65,150.00. Following the acquisition, the chief executive officer now directly owns 205,880 shares of the […]
Equities research analysts forecast that Sierra Oncology, Inc. (NASDAQ:SRRA – Get Rating) will announce earnings of ($0.95) per share for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Sierra Oncology’s earnings, with the highest EPS estimate coming in at ($0.88) and the lowest estimate coming in at ($1.02). Sierra […]
Analysts forecast that ESSA Pharma Inc. (NASDAQ:EPIX – Get Rating) (TSE:EPI) will post earnings of ($0.27) per share for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for ESSA Pharma’s earnings, with the highest EPS estimate coming in at ($0.24) and the lowest estimate coming in at ($0.29). ESSA Pharma posted […]